Bernard Kwabi-Addo obtained his Ph.D. degree in the field of biochemistry and molecular biology from Queen Mary and Westfield College, London, UK, where he carried out studies using Cre-loxP site-specific recombination system to design chromosomal translation in transgenic animal model. He is currently working as an Associate Professor of biochemistry and molecular biology at Howard University, Washington, DC, USA. Dr. Kwabi-Addo carried out his postdoctoral training at Baylor College of Medicine, Houston, Tex, USA, where he studied the molecular mechanisms underlying dysregulation of receptor tyrosine signaling in prostate cancer. He subsequently joined Howard University Cancer Center, Washington, DC, USA, as an Assistant Professor. Dr. Kwabi-Addo has so far published more than 23 papers in international peer-reviewed journals on prostate cancer research and has also written reviews in this very same field. In addition, Dr. Kwabi-Addo is the Principal Investigator of a prostate cancer research laboratory investigating the role of epigenetic alterations in regulating gene expression in prostate cancer etiology and/or progression. His main areas of research expertise are prostate cancer, receptor tyrosine kinase signaling, epigenetic DNA methylation changes, cancer disparities, and cancer prevention.
Biography Updated on 16 October 2013